Halozyme Therapeutics (HALO) Stock Chart - Revenue & Earnings | Quarter Chart
📊 Income Statement ▲
Revenue by Product
RoyaltyProductCollaborative AgreementsBulk rHuPH20Upfront feesbulk rHuPH20
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
RevenueGross ProfitOperating IncomeNet Income
Margin (%)
Gross MarginOperating MarginNet Income Margin
Operating Expenses
Research And Development ExpensesSelling General And Administrative Expenses
EBITDA
EBITDA
EPS
EPSEPS Diluted
Revenue Variation (%)
Revenue Variation
Income Variation (%)
Gross Profit VariationOperating Income VariationNet Income Variation
Revenue YoY Variation (%)
Revenue YoY Variation
Income YoY Variation (%)
Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
Price-to-Earning Ratio
P/E Ratio
Income Breakdown
Rule Of 40 (EBITDA)Rule Of 40 (FCF)
Per Share Metrics
Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
Expense Ratios
Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
💰 Cash Flow Statement ▲
Operating Cash Flow
Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
Free Cash Flow
Operating Cash FlowCapital ExpenditureFree Cash Flow
Cash Flow to Debt Ratio
Cash At End Of Period
🏦 Balance Sheet ▼
📈 Key Metrics ▼